Change of Company Name
14 9월 2007 - 1:14AM
UK Regulatory
RNS Number:8322D
BioProgress PLC
13 September 2007
For Immediate Release 13 September 2007
BioProgress plc
BioProgress plc completes name change to Meldex International Plc
London, UK, 13 September 2007: BioProgress Plc ('BioProgress' or the 'Company')
(AIM: BPRG), the specialty pharma and healthcare company, is pleased to announce
that at its EGM held earlier today, the resolution to change the Company's name
from BioProgress Plc to Meldex International Plc was duly passed.
The Company will trade trade under the ticker MDX on the AIM market with effect
from 14 September 2007.
For further information:
BioProgress Plc + 44 (0) 20 7098 9881
Richard Trevillion, CEO
Steve Martin, CDO
Hiral Patel, CFO
Buchanan Communications + 44 (0) 20 7466 5000
Rebecca Skye Dietrich
Mark Court
About BioProgress
BioProgress plc is an innovative specialty pharmaceutical and healthcare
business based around its platform technologies in polymer and film systems.
Listed on London's AIM in May 2003, The company has over 80 patents granted or
in application within 24 patent families and has product development agreements
and strategic alliances with several global companies. As a virtually integrated
business, BioProgress has acquired sales and marketing resources within Europe
and the US as a launch mechanism for its own pharmaceutical products. The
business continues to develop innovative delivery mechanisms using its XGELTM
polymer technology. For further information please go to www.bioprogress.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
CANMGGMLVFMGNZM
Bioprogress (LSE:BPRG)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Bioprogress (LSE:BPRG)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
Bioprogress (London Stock Exchange)의 실시간 뉴스: 최근 기사 0
More Bioprogress Plc News Articles